Progestin therapy for causing endometrial atrophy while...

Details Progestin therapy for causing endometrial atrophy while... Progestin therapy for causing endometrial atrophy while...

A - Human Necessities

61

K

A61K 31/57 (2006.01) A61K 9/10 (2006.01) A61P 5/34 (2006.01) A61P 15/00 (2006.01) A61K 47/32 (2006.01) A61M 31/00 (2006.01)

Patent

CA 2649671

Disclosed is a progestin therapy to cause endometrial atrophy while maintaining amenorrhea in a woman, by constant vaginal administration of progestin twice per week via a drug delivery system (or a pharmaceutical composition) comprising a water-insoluble water-swellable cross-linked polycarboxylic acid polymer and 4% by weight of progestin.

Affiliated with

Also associated with

Rating

Progestin therapy for causing endometrial atrophy while... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Progestin therapy for causing endometrial atrophy while..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Progestin therapy for causing endometrial atrophy while... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1628391